J J Lipsky|D C Mays|S Naylor - JoVE Visualize

Showing results (11-20 of 269) with videos related to

Pageof 27

Sort By:

Biochemical Pharmacology|September 7, 2000

Role of disulfiram in the in vitro inhibition of rat liver mitochondrial aldehyde dehydrogenaseM L Shen, J J Lipsky, S Naylor

Chemico-Biological Interactions|April 18, 2001

Overview--in vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolitesJ J Lipsky, M L Shen, S Naylor

Chemico-Biological Interactions|April 18, 2001

In vivo inhibition of aldehyde dehydrogenase by disulfiramJ J Lipsky, M L Shen, S Naylor

Biochemistry|September 22, 2000

Rat liver constitutive and phenobarbital-inducible cytosolic aldehyde dehydrogenases are highly homologous proteins that function as distinct isozymesE C Kathmann, S Naylor, J J Lipsky

FEBS Letters|March 27, 1998

Diadenosine 5',5"-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heartA Jovanovic, S Jovanovic, D C Mays, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2001

Metabolism of a disulfiram metabolite, S-methyl N,N-diethyldithiocarbamate, by flavin monooxygenase in human renal microsomesM G Pike, D C Mays, D W Macomber, et al.

Alcoholism, Clinical and Experimental Research|May 1, 1996

S-methyl-N,N-diethylthiocarbamate sulfoxide and S-methyl-N,N-diethylthiocarbamate sulfone, two candidates for the active metabolite of disulfiramD C Mays, A N Nelson, J Lam-Holt, et al.

Inflammatory Bowel Diseases|January 10, 2001

Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel diseaseL J Egan, W J Tremaine, D C Mays, et al.

Alimentary Pharmacology & Therapeutics|August 13, 1998

Dialysis of the rectum for sampling drug concentrations in the luminal extracellular fluid of the gut: technique and precisionL J Egan, W J Sandborn, D C Mays, et al.

Inflammatory Bowel Diseases|August 24, 1999

Plasma and rectal adenosine in inflammatory bowel disease: effect of methotrexateL J Egan, W J Sandborn, D C Mays, et al.

Pageof 27

Showing results (11-20 of 269) with videos related to

Sort By:

Pageof 27

Biochemical Pharmacology|September 7, 2000

Role of disulfiram in the in vitro inhibition of rat liver mitochondrial aldehyde dehydrogenaseM L Shen, J J Lipsky, S Naylor

Chemico-Biological Interactions|April 18, 2001

Overview--in vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolitesJ J Lipsky, M L Shen, S Naylor

Chemico-Biological Interactions|April 18, 2001

In vivo inhibition of aldehyde dehydrogenase by disulfiramJ J Lipsky, M L Shen, S Naylor

Biochemistry|September 22, 2000

Rat liver constitutive and phenobarbital-inducible cytosolic aldehyde dehydrogenases are highly homologous proteins that function as distinct isozymesE C Kathmann, S Naylor, J J Lipsky

FEBS Letters|March 27, 1998

Diadenosine 5',5"-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heartA Jovanovic, S Jovanovic, D C Mays, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2001

Metabolism of a disulfiram metabolite, S-methyl N,N-diethyldithiocarbamate, by flavin monooxygenase in human renal microsomesM G Pike, D C Mays, D W Macomber, et al.

Alcoholism, Clinical and Experimental Research|May 1, 1996

S-methyl-N,N-diethylthiocarbamate sulfoxide and S-methyl-N,N-diethylthiocarbamate sulfone, two candidates for the active metabolite of disulfiramD C Mays, A N Nelson, J Lam-Holt, et al.

Inflammatory Bowel Diseases|January 10, 2001

Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel diseaseL J Egan, W J Tremaine, D C Mays, et al.

Alimentary Pharmacology & Therapeutics|August 13, 1998

Dialysis of the rectum for sampling drug concentrations in the luminal extracellular fluid of the gut: technique and precisionL J Egan, W J Sandborn, D C Mays, et al.

Inflammatory Bowel Diseases|August 24, 1999

Plasma and rectal adenosine in inflammatory bowel disease: effect of methotrexateL J Egan, W J Sandborn, D C Mays, et al.

Pageof 27